Medicine Man Tech Inc (SHWZ) Q2 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, my name is Sergio and I will be your conference operator today. At this time, I would like to welcome everyone to Strass's second quarter 2023 conference call. All lines have been placed on mute to prevent any background noise. Following their prepared remarks, management will take questions submitted via the web link found on Strass's investor relations website and in the earnings press release. I would now like to hand the conference over to the company's external head of investor relations, Sean Mansoury with Elevate IR. Sir, please go ahead. Good afternoon, and welcome to Schwoz's second quarter 2023 earnings conference call. Joining me on the call are Justin Dye, Schwoz's chairman of the board, Nirup Krishnamurthy, chief executive officer, and Forrest Hoffmaster, chief financial officer. The company will begin with prepared remarks, and then we will open the call for Q&A. I'd like to remind you that management's prepared remarks and answers to your submitted questions may contain forward-looking statements, which are subject to risks and uncertainties. Examples of forward-looking statements include, among others, statements regarding federal and state legislation and regulation, Schwoz's future results of operations and financial position, and Schwoz's business strategy and plans and objectives for future operations. Such forward-looking statements may be preceded by the words plan, will, may, continue, anticipate, become, build, develop, expect, believe, poised, project, approximate, could, potential, or similar expressions as they relate to Schwoz. Investors are cautioned that all forward-looking statements involve risks and uncertainties that may cause actual events, results, performance, or achievements to differ from those anticipated by Sch...